Surgical Glaucoma Specialist

Job not on LinkedIn

🔥 8 minutes ago

🇬🇧 United Kingdom – Remote

⏰ Full Time

🟢 Junior

🟡 Mid-level

🚫👨‍🎓 No degree required

👻 Ghost score 12%

What it means: how likely this posting is sitting open without active hiring.How to read it: 60% or higher means we think this is a ghost. Lower scores are less of a worry.How we score it: age, reposts, open roles vs team size, how fast jobs close, and whether pay is listed.Fine print: an estimate from public data, not a judgment of the company. Real jobs can score high, so treat it as a hint, not a fact.

Apply Now

Find Similar Remote Jobs

Set Up Email Alert For New Jobs

📊 Check your resume score for this job

Improve your chances of getting an interview by checking your resume score before you apply.

Upload Resume

CILIATECH - Glaucoma Innovators

WebsiteLinkedInAll Job Openings

11 - 50 employees

Founded 2017

🏥 Healthcare

💼 Consulting

🏭 Manufacturing

💰 $1.9M Debt Financing - Ciliatech on 2023-04

Healthcare • Consulting • Manufacturing

CILIATECH - Glaucoma Innovators is a medical technology company that develops the Intercil® Uveal Spacer, an implantable supraciliary device designed to lower intraocular pressure in primary open-angle and angle-closure glaucoma. The company emphasizes an ab-externo, bleb-free surgical approach that avoids entry into the anterior chamber, aiming to reduce endothelial cell risk and postoperative burdens while preserving future surgical options. CILIATECH supports its product with multi-year clinical trials and targets ophthalmic surgeons and professional audiences in glaucoma care.

📋 Description

• Execute the launch of Ciliatech’s Intercil Uveal Spacer with Ophthalmologists in the field • Train glaucoma surgeons and Key Opinion Leaders to a very high standard in commercially inactive new accounts • Maximise sales and uptake of Intercil • Identify high-potential surgeons, accounts, and geographical regions within the sales territory • Develop business plans to achieve and exceed predefined sales targets • Monitor progress against sales execution plans and update business plans • Negotiate with key hospital accounts to achieve favorable terms for Ciliatech products • Identify, book, arrange, and attend key customer events, congresses, and customer meetings • Monitor promotional spend against annual budgets • Execute optimal customer follow-up schedules to maintain relationships, share best practices, and grow sales within accounts • Participate in KOL development activities as directed by senior leadership • Master Ciliatech products, including concepts, clinical data, surgical technique, indications, and conditions • Become an expert on competitors and alternative treatment modalities • Train surgeons and operating-room staff on safe and successful implantation procedures • Attend national and international congresses as directed • Follow MIGS industry trends and publications to maintain current competitor and disease-area knowledge

🎯 Requirements

• Minimum 2 years’ surgical sales experience in the operating room • Experience in Ophthalmology • Fluent in written and spoken English • Strong emotional intelligence and excellent communication skills • Natural relationship builder with a customer-first mindset • High personal drive, results-oriented, and goal-focused • Confident, fair, and adaptable in fast-paced environments • Positive, energetic team player with a hands-on mindset • Well-organized and able to manage multiple priorities • Comfortable with frequent travel and flexible schedules • Experience in the Glaucoma sub-specialty preferred • Experience in MIGS preferred • Based in South UK • Reliable car suitable for frequent business travel • Full clean driving license is mandatory • Availability for extensive national travel, short-notice travel, and multiple nights away from home • Ability to pass validations/exams and achieve official certification as a surgical trainer

🏖️ Benefits

• Car allowance • Opportunity to join a genuinely dynamic and growing environment • Direct responsibility and visibility in the launch of an innovative glaucoma device to global markets